Skip to main content

Global Genomics Market Tends to Expand at a CAGR of 11.2% during Forecast Period 2017-2025


According to Goldstein Research, Global genomics market is anticipated to grow at a CAGR of 11.2% over the forecast period 2017-2025 to reach USD 24.5 billion by 2025. Adoption of genome editing/genome engineering in genomics which are used for cell line engineering, genetic engineering, diagnostics and therapeutics are expected to positively reinforce genomics market. However, the complex nature of the drugs coupled with high development costs, sub-optimal development framework and inter-patient variability of effects contributing to potential barriers that are integrating genomics into underserved medical settings are intensely challenging the growth of market. Global genomics market segmentation has been done on the basis of product type, technology, application, end user and geography.
Global Genomics Market segmentation based on application, diagnostics application segment dominated in 2017 with 32.5% market share due to accuracy of gene-based diagnostics of variable diseases. Personalized medicine market is expected to grow at the highest CAGR of 11.42% during the forecast period. Genomics market is largely dominated by Europe with a market share of 37.25% in 2017. Whereas APAC is expected to witness the most significant development owing to strengthening economies of developing countries such as India and China. North America genomics market will grow at the substantial rate due to the ample amount of funds and presence of companies undertaking research in the field of genomics. 

Market Segmentation
On the basis of our in-depth analysis, Global Genomics Market can be segmented and sub-segmented as follows:

Genomics Market, Based on Product Type

  • Instruments
  •   Consumable
  •  Services


Genomics Market, Based on Technology

  • ·         Microarray Technology
  • ·         PCR
  • ·         DNA Sequencing
  • ·         Nucleic Acid Extraction & Purification
  • ·         Others (Gene Expression, etc)


Genomics Market, Based on Application

  • ·         Diagnostics (Prenatal diagnosis and testing)
  • ·         Infectious diseases
  • ·         Pharmacogenetics and targeted therapy
  • ·         Personalized Medicines
  • ·         Gene Therapy
  • ·         Genome Editing
  • ·         Agriculture Research
  • ·         Others (Marine Research, biofuels, and coal mines)


Genomics Market, Based on End User
  • Hospitals & Clinics
  • Research & Development Centers 
  • Pharmaceutical and Biotechnology Companies 
  • Agri-genomics organizations


Genomics Market, By Region
·         North America (United States, Canada) {Market Share (%), Market Size (USD Billion, Adoption Rate (%)}
·         Europe (UK, France, Italy, Germany, Spain, Hungary, Sweden, Russia, Poland and Rest of Europe) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
·         Middle East and Africa (GCC Countries, North Africa, South Africa and Rest of Middle East & Africa) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
·         Latin America (Brazil, Mexico and Rest of Latin America) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
·         Asia Pacific genomics Market (China, Japan, India, Singapore, South Korea, Australia, New Zealand and Rest of Asia-Pacific) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}


“Genomics Market Outlook 2025” contains a detailed overview of the global genomics market. On the basis of our in-depth analysis, market can be segmented in terms of market segmentation by product type, technology, application and end user.
Further, for the in-depth analysis, Global Genomics Market Report technology and end-user encompasses the industry growth drivers, market challenges, risk analysis, market attractiveness, BPS (Base Point Scale) analysis, Porter’s five force model and SWOT analysis.
This industry analysis report also includes competitive outlook of some of the major players profiling of companies such as Bayer AG, Affymetrix Inc., Agilent Technologies, Inc., Genomatix Software Inc., Navigenics, Inc., Roche Diagnostics, Myriad Genetics, Inc., QIAGEN, Inc., Illumina, Inc., GE Healthcare, Thermo Fisher Scientific, Eurofins Scientific, BGI,  Bio-Rad Laboratories, Oxford Nanopore Technologies, Pacific Biosciences of California, Eppendorf, etc. The company profiles include business strategy, geographical revenue distribution, major information of the companies which encompasses business outlook, products, services and industries catered, financial analysis of the company and recent developments.
Objective of Report:
  • ·         To analyze and forecast market size of genomics market.
  • ·         To calculate the expected growth rate of genomics market.
  • ·         To classify and forecast genomics market based on product type, technology, application, end user and geography.
  • ·         To identify market key players, driving factors, & trends of genomics market with the help of SWOT Analysis.
  • ·         To identify and analyze the profiles of leading players involved in the manufacturing and supplying of genomics market.
  • ·         To identify market opportunities for the existing and entry level players.


Overall, the report represents the global genomics market trends along with market forecast that will help industry consultants, technology providers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

Download Exclusive Sample Report: https://www.goldsteinresearch.com/request-sample/global-genomics-market-size-industry-forecast
About Goldstein Research
Based in the US, Goldstein Research currently has a strong presence in the American and Asian countries. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions.
Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear cut forecasts. Our market research reports provide in-depth analysis of global and regional variations along with competitors’ overview. Our analysts working on healthcare industry reports to help various tech-giants, tech start-ups and entry players to assess the current and upcoming business scenario. We believe in vigorous examination of the current market scenario and build around creative ideas and approaches that are most suitable to our clients’ needs and business agenda.
Contact for more Info:
Steve Blade
(Global Sales Head)
USA: + 1-646-568-7747
Canada: +1-437-886-1181
UK: +44-203-318-6627
sales@goldsteinresearch.com

www.goldsteinresearch.com

Comments

Post a Comment

Popular posts from this blog

Global Behavioral/Mental Health Software Market Projected to Grow at a Robust CAGR of 13.49% over the Forecast Period 2016-2024

With high incidences in adoption of e-mental health services has led to be major driving factor for the growth of global behavioural/mental health software market . According to Goldstein Research, global behavioral/mental health software market size is expected to reach USD 2.35 billion by 2024, growing at a compounded annual growth rate of 13.49% during the forecast period 2016-2024. Global behavioral/mental health software market segmentation has been carried out on the basis of delivery mode, functionality, end user and geography. Based on delivery mode, subscription segment accounted for 74.25% behavioural/mental health software market share , owing to increasing acceptance of electronic health record systems. Further, Global behavioral/mental health software industry is estimated to be dominated by North America with a market share of 47.2% in 2016. Whereas, Asia Pacific is anticipated to be the opportunistic market, growing at a CAGR of 13.98% during the forecast period. ...
Post a Comment
Read more

Global Dead Sea Mud Cosmetic Market Outlook: Trends, Demand Analysis, Size, Share, & Forecast

According to Goldstein Research, intensifying inclination of consumers towards natural ingredients and organic products is the major factor motivating the demand for dead sea cosmetics. Moreover, limited availability can be attributed to the very small number of players in the Dead Sea mud cosmetics market. The market can be said to be oligopolistic in nature, with only a handful of players. Global dead sea mud cosmetic market outlook also includes product development, marketing and investment strategies adopted by major market players in order to expand their business across the globe. However, depletion of the Dead Sea and rising ecological concerns around it can potentially pose challenges for the Dead Sea mud cosmetics market over the forecast period. Market Segmentation On the basis of our in-depth analysis, global dead sea mud cosmetic market can be segmented as follows: By Product Type Facial Care ProductsFace WashesFace MoisturizersFace Serums Body Care ProductsBod...
Post a Comment
Read more

Changing Diagnostic Paradigms With The Revolution In Point Of Care Testing

A recurring theme in healthcare is that the  diagnostics industry  is on the cusp of a major transformation that will see an evolved role for point-of-care (POC) tests that can be run at the bedside, in doctors’ offices, at pharmacies or in people’s homes. This industry tends to transform with the computing revolution rendering many types of mainframe computers obsolete, as the price of manufacturing POC tests drops and the potential for running multiplex tests in miniature expands. Point of Care Testing (POCT) Devices Market Shift to Self Care Diagnosis Emphasis of care has shifted from the prevention and early detection of disease to the ability to get involved and diagnose themselves. Dominant area in POC is glucose monitoring, which require self-monitor and diagnose as diabetes patients needs to be regularly test themselves means that the ease of access to, and functionality of, POC testing is perfectly suited to their conditions. Portability: Trend in POC...
Post a Comment
Read more